These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7832846)

  • 21. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
    Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study.
    Bilbault P; Oubaassine R; Rahmani H; Lavaux T; Castelain V; Sauder P; Schneider F
    Eur J Emerg Med; 2009 Jun; 16(3):145-9. PubMed ID: 19262393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments.
    Pentel PR; Ross CA; Landon J; Sidki A; Shelver WL; Keyler DE
    J Lab Clin Med; 1994 Mar; 123(3):387-93. PubMed ID: 8133150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
    Valentine JL; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments.
    Baud FJ; Sabouraud A; Vicaut E; Taboulet P; Lang J; Bismuth C; Rouzioux JM; Scherrmann JM
    N Engl J Med; 1995 Mar; 332(10):642-5. PubMed ID: 7845428
    [No Abstract]   [Full Text] [Related]  

  • 26. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circuitous diagnosis in concealed self-poisoning with Nerium oleander.
    Vallé B; Lairez O; Gandia P; Rouge D; Franchitto N
    Clin Toxicol (Phila); 2012 Mar; 50(3):228-9. PubMed ID: 22335506
    [No Abstract]   [Full Text] [Related]  

  • 28. [Digitalis antidote].
    Naturwissenschaften; 1984 Apr; 71(4):208. PubMed ID: 6728035
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotoxicotherapy: successes, disappointments and hopes.
    Bismuth C; Borron SW; Baud FJ; Taboulet P; Scherrmann JM
    Hum Exp Toxicol; 1997 Oct; 16(10):602-8. PubMed ID: 9363479
    [No Abstract]   [Full Text] [Related]  

  • 30. Antidotes in the treatment of acute poisoning.
    Lange PG; Moores K
    Iowa Med; 1987 Aug; 77(8):396-404. PubMed ID: 3654158
    [No Abstract]   [Full Text] [Related]  

  • 31. [Digitalis poisoning treated with a specific antidote].
    Rykke EO; Bredesen JE; Stokland O; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Jan; 118(3):408-10. PubMed ID: 9499730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.
    Seifert SA; Boyer LV
    Ann Emerg Med; 2001 Feb; 37(2):189-95. PubMed ID: 11174238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies.
    Kurowski V; Iven H; Djonlagic H
    Intensive Care Med; 1992; 18(7):439-42. PubMed ID: 1469187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of the pharmacological and toxic effects of cardiac glycosides by specific antibodies.
    Butler VP; Watson JF; Schmidt DH; Gardner JD; Mandel WJ; Skelton CL
    Pharmacol Rev; 1973 Jun; 25(2):239-48. PubMed ID: 4581043
    [No Abstract]   [Full Text] [Related]  

  • 35. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and management of digitalis poisoning--rationale for immunotherapy.
    Taboulet P; Baud FJ; Bismuth C
    J Toxicol Clin Toxicol; 1993; 31(2):247-60. PubMed ID: 8492338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotoxicotherapy: present status and future trends.
    Scherrmann JM; Terrien N; Urtizberea M; Pierson P; Denis H; Bourre JM
    J Toxicol Clin Toxicol; 1989; 27(1-2):1-35. PubMed ID: 2671404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
    Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
    Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strongly enhanced toxicity of the mushroom toxin alpha-amanitin by an amatoxin-specific Fab or monoclonal antibody.
    Faulstich H; Kirchner K; Derenzini M
    Toxicon; 1988; 26(5):491-9. PubMed ID: 3188055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.